Effects of Pay-For-Performance on Prescription of Hypertension Drugs among Public and Private Primary Care Providers in Sweden

Arbeitspapier

This study exploits policy reforms in Swedish primary care to examine the effect of pay-for-performance (P4P) on compliance with hypertension drug guidelines among public and private health care providers. Providers in regions with P4P are compared to providers in other regions in a difference-in-differences analysis using data from the Swedish Prescription Register for the period 2005-2013. The results indicate that P4P improved guideline compliance regarding prescription of Angiotensin Converting Enzyme (ACE) inhibitors and Angiotensin Receptor Blockers (ARB). The effect is mainly driven by private providers, suggesting that policy makers should take ownership into account when designing incentives for health care providers.

Object Details

• Language: Englisch

References and Relationships

• Bibliographic citation: Series: Working Paper ; No. 2018:6

Classification and Topics

• Classification: Wirtschaft ; Organizational Behavior; Transaction Costs; Property Rights ; State and Local Government; Intergovernmental Relations: Interjurisdictional Differentials and Their Effects ; Analysis of Health Care Markets ; Health: Government Policy; Regulation; Public Health ; Compensation Packages; Payment Methods
• Subject: Pay-for-performance ; Hypertension treatment ; Ownership ; Primary health care

Contributors, Places and Time

• Event: Geistige Schöpfung
• (who): Ellegård, Lina Maria
• Event: Veröffentlichung
• (who): Lund University, School of Economics and Management, Department of Economics
• (where): Lund
• (when): 2018

Further information

• Handle: http://hdl.handle.net/10419/260235
• Last update: 10.03.2025, 11:42 AM CET